Literature DB >> 18703806

Proposal for a universal definition of cerebral infarction.

Jeffrey L Saver1.   

Abstract

BACKGROUND AND
PURPOSE: Cerebral infarction is a leading cause of disability and death worldwide but has no uniform international definition. SUMMARY OF REVIEW: Recent diagnostic advances have revised fundamental concepts in cerebral and cardiac ischemia. Cardiologists, already possessed of a nosologic framework distinguishing myocardial infarction from unstable angina on the basis of tissue state, promulgated a new "universal" tissue definition of myocardial infarction incorporating insights afforded by assays of cardiac troponin, a serum biomarker exquisitely sensitive to myocardial injury. Concurrently, vascular neurologists proposed a new tissue, rather than time, criterion to distinguish transient ischemia attack from cerebral infarction, responding to perspectives provided by diffusion MRI and cerebral blood volume CT, imaging biomarkers highly sensitive to neuronal injury. To complete this conceptual realignment, vascular neurology must now advance a clear, uniform, and operationalizable tissue definition of cerebral infarction. This review proposes cerebral infarction be defined as brain or retinal cell death due to prolonged ischemia. This definition categorizes both pannecrosis and neuronal dropout ("complete" and "incomplete" infarcts in classic neuropathologic terminology) as cerebral infarcts. Making the presence of any neuronal or glial cell death essential yields a definition of cerebral infarction that has high relevance to patients, physicians, and policymakers; is more easily applied in clinical practice; fosters action in acute care; harmonizes with myocardial ischemia classification; and focuses diagnostic evaluation on the cause of brain ischemia and the occurrence of end organ injury.
CONCLUSIONS: The term cerebral infarction should be used when there is evidence of brain or retinal cell death due to cerebral ischemia.

Entities:  

Mesh:

Year:  2008        PMID: 18703806     DOI: 10.1161/STROKEAHA.108.518415

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

1.  Association Between Gastric Emptying Time and Incidence of Cardiovascular Diseases in Subjects With Diabetes.

Authors:  Hyung-Min Park; Seon-Young Park; Jin Ook Chung; Dong Hyuk Cho; Chang-Hwan Park; Hyun-Soo Kim; Dong Jin Chung; Sung-Kyu Choi; Jong-Sun Rew; Min Young Chung
Journal:  J Neurogastroenterol Motil       Date:  2019-07-01       Impact factor: 4.924

2.  The power combination of blood-pressure parameters to predict the incidence of plaque formation in carotid arteries in elderly.

Authors:  Chang-Ning Hao; Yi-Qin Shi; Jing-Juan Huang; Hao-Yun Li; Zhen-Hao Huang; Xian-Wu Cheng; Wei Lu; Jun-Li Duan
Journal:  Int J Clin Exp Med       Date:  2013-06-26

Review 3.  GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease.

Authors:  Dongdong Wang; Emily A Day; Logan K Townsend; Djordje Djordjevic; Sebastian Beck Jørgensen; Gregory R Steinberg
Journal:  Nat Rev Endocrinol       Date:  2021-08-11       Impact factor: 43.330

4.  Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium.

Authors:  Martin B Leon; Nicolo Piazza; Eugenia Nikolsky; Eugene H Blackstone; Donald E Cutlip; Arie Pieter Kappetein; Mitchell W Krucoff; Michael Mack; Roxana Mehran; Craig Miller; Marie-Angèle Morel; John Petersen; Jeffrey J Popma; Johanna J M Takkenberg; Alec Vahanian; Gerrit-Anne van Es; Pascal Vranckx; John G Webb; Stephan Windecker; Patrick W Serruys
Journal:  Eur Heart J       Date:  2011-01-06       Impact factor: 29.983

5.  Association between Diabetic Polyneuropathy and Cardiovascular Complications in Type 2 Diabetic Patients.

Authors:  Jin Ook Chung; Dong Hyeok Cho; Dong Jin Chung; Min Young Chung
Journal:  Diabetes Metab J       Date:  2011-08-31       Impact factor: 5.376

6.  Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study.

Authors:  Veena Hoffman; Jesper Hallas; Marie Linder; Andrea V Margulis; Brandon T Suehs; Alejandro Arana; Kelesitse Phiri; Cheryl Enger; Libby Horter; Ingvild Odsbu; Morten Olesen; Susana Perez-Gutthann; Yihua Xu; Nina Sahlertz Kristiansen; Kwame Appenteng; Stefan de Vogel; John D Seeger
Journal:  Drug Saf       Date:  2021-07-08       Impact factor: 5.606

Review 7.  Arachidonic Acid and Cerebral Ischemia Risk: A Systematic Review of Observational Studies.

Authors:  Mai Sakai; Saki Kakutani; Hisanori Tokuda; Toshihide Suzuki; Masaru Kominami; Kahori Egawa; Kayo Saito; Tomohiro Rogi; Hiroshi Kawashima; Hiroshi Shibata; Satoshi Sasaki
Journal:  Cerebrovasc Dis Extra       Date:  2014-11-05

8.  Prediction of infarction development after endovascular stroke therapy with dual-energy computed tomography.

Authors:  Tanja Djurdjevic; Rafael Rehwald; Michael Knoflach; Benjamin Matosevic; Stefan Kiechl; Elke Ruth Gizewski; Bernhard Glodny; Astrid Ellen Grams
Journal:  Eur Radiol       Date:  2016-06-02       Impact factor: 5.315

9.  Respiratory Function and Grip Strength in the Acute Phase of Stroke Are Associated with Stroke Severity and Disability at Hospital Discharge.

Authors:  Lorena Cristina Alvarez Sartor; Gustavo José Luvizutto; Juli Thomaz de Souza; Evelin Roberta Silva Dalle Molle; Gabriel Pinheiro Modolo; Taís Regina da Silva; Robson Aparecido Prudente; Priscila Watson Ribeiro; Rafael Dalle Molle da Costa; Letícia Cláudia de Oliveira Antunes; Natália Cristina Ferreira; Silméia Garcia Zanati Bazan; Fernanda Cristina Winckler; Hélio Rubens de Carvalho Nunes; Marcos Ferreira Minicucci; Rodrigo Bazan
Journal:  Rehabil Res Pract       Date:  2020-02-03

10.  Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom.

Authors:  Alejandro Arana; Andrea V Margulis; Cristina Varas-Lorenzo; Christine L Bui; Alicia Gilsenan; Lisa J McQuay; Maria Reynolds; Cristina Rebordosa; Billy Franks; Stefan de Vogel; Kwame Appenteng; Susana Perez-Gutthann
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-10-28       Impact factor: 2.890

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.